Fig. 6From: Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysisProbabilistic sensitivity analysis for the test strategy compared with the usual care strategy assuming 20Â % of the test positive patients adhered to warfarin therapy. The cost-effectiveness plane shows the effect of simultaneously varying all model parameters on incremental cost (per 1000 patients, vertical axis) and incremental effectiveness (per 1000 patients, horizontal axis) in 10,000 Monte Carlo simulationsBack to article page